Amphastar Pharmaceuticals, Inc.
AMPH
Revenue
191.84M
▲17.43M▲9.99%
3 Months ChangeAssets
1.67B
▲50.89M▲3.15%
3 Months ChangeLiabilities
889.48M
▲31.63M▲3.69%
3 Months ChangeFree Cash Flow
24.38M
▼-22.12M▼-47.57%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-30
Form 8-K
ID: 0001297184-24-000051
2024-08-09
Form 10-Q
ID: 0001297184-24-000048
2024-08-07
Form 8-K
ID: 0001297184-24-000045
2024-06-04
Form 8-K
ID: 0001297184-24-000042
2024-05-10
Form 10-Q
ID: 0001297184-24-000037
2024-05-08
Form 8-K
ID: 0001297184-24-000033
2024-02-28
Form 8-K
ID: 0001297184-24-000004
2023-11-08
Form 10-Q
ID: 0001297184-23-000082
2023-11-08
Form 8-K
ID: 0001297184-23-000079
2023-09-15
Form 8-K
ID: 0001297184-23-000074